Compare Becton Dickinson and Co (BDX) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Exxon Mobil Corporation — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while Exxon Mobil Corporation trades at $145.11 (market cap $601.39B). The key difference: Exxon Mobil Corporation is far larger — about 14.5× Becton Dickinson and Co's market cap, and Exxon Mobil Corporation pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| BDX | XOM | |
|---|---|---|
Market Cap | $41.51B | $601.39B |
Sector | Health | Energy |
52-Week High | $185.39 | $171.52 |
52-Week Low | $135.49 | $105.83 |
Enterprise Value | $57.97B | $640.62B |
Dividend Yield | 2.79% | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
ExxonMobil (XOM) trades at $145.09, up 4.51% today, with strong technical momentum and bullish moving average signals. The company maintains solid profitability with 7.76% net margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights Exxon's Permian Basin advantages and potential oil price spikes to $150-160 per barrel, while the company relocates its headquarters to Texas for business-friendly policies.
XOM presents a compelling investment case with analyst consensus target of $169.30 (17% upside), though risks include declining revenue trends (2025: $323.9B vs 2022: $398.7B) and oil price volatility. The stock's 24.33 P/E appears reasonable given operational strength, but investors should monitor execution on production targets and global energy market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
